---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-054867"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2025-05-30T23:59:59+00:00"
generated_at: "2026-05-20T04:25:19.459775+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TELA Bio stockholders approve 3.5M share increase to equity plan and officer liability limitation

## Summary
- Class III directors Blizard, Burgess, O'Brien elected; Burgess received only 9.75M votes for vs 19.54M withheld.
- Equity plan amendment approved (20.03M for, 9.25M against); adds 3.5M shares, removes evergreen provision.
- Charter amendment to limit officer liability passed (23.84M for, 5.41M against).
- Non-binding say-on-pay approved with 23.03M for; annual frequency selected (26.94M for 1-year).
- KPMG LLP ratified as auditor for 2025 with 31.84M votes for.

## SEC filing metadata
- accession: 0001104659-25-054867
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2025-05-30T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465925054867/0001104659-25-054867-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465925054867/tm2516546d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-054867
- JSON: https://secwatch.observer/filing/0001104659-25-054867.json
- Plain text: https://secwatch.observer/filing/0001104659-25-054867.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.